Literature DB >> 1481362

Round table on epidemiology and control of fox rabies.

U Kihm1, A Flamand, P P Pastoret, E Peterhans.   

Abstract

The current epizootic of rabies in Europe has as its main host the fox. Oral vaccination of the fox population has proven to be particularly effective. It is clear that the major components for a successful vaccination programme are a potent and stable vaccine, and an effective baiting system; the latter should attract the target animal but no non-target species. Recently, vaccines of increased stability have been generated; amongst these is a vaccinia recombinant virus which expresses rabies virus glycoprotein. Consequently, both attenuated live virus vaccines and a recombinant vaccine are available for routine field vaccination of the fox population.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1481362     DOI: 10.1016/0378-1135(92)90057-z

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  4 in total

1.  Promising rabies vaccine for postexposure prophylaxis in developing countries, a purified vero cell vaccine produced in china.

Authors:  Chuanlin Wang; Xiaowei Zhang; Qingkun Song; Kun Tang
Journal:  Clin Vaccine Immunol       Date:  2010-02-10

2.  Rabies trend in China (1990-2007) and post-exposure prophylaxis in the Guangdong province.

Authors:  Han Si; Zhong-Min Guo; Yuan-Tao Hao; Yu-Ge Liu; Ding-Mei Zhang; Shao-Qi Rao; Jia-Hai Lu
Journal:  BMC Infect Dis       Date:  2008-08-21       Impact factor: 3.090

Review 3.  Immunoprophylaxis against important virus disease of horses, farm animals and birds.

Authors:  J R Patel; J G M Heldens
Journal:  Vaccine       Date:  2009-03-13       Impact factor: 3.641

Review 4.  Veterinary vaccine development from an industrial perspective.

Authors:  J G M Heldens; J R Patel; N Chanter; G J Ten Thij; M Gravendijck; V E J C Schijns; A Langen; Th P M Schetters
Journal:  Vet J       Date:  2008-03-03       Impact factor: 2.688

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.